Expected Implications of Globally Coordinated Cessation of Serotype 3 Oral Poliovirus Vaccine (OPV) Before Serotype 1 OPV-Reference-Cited by-同舟云学术

Expected Implications of Globally Coordinated Cessation of Serotype 3 Oral Poliovirus Vaccine (OPV) Before Serotype 1 OPV

Published:2020-09-16 Issue:2 Volume:41 Page:312-319
ISSN:0272-4332
Container-title:Risk Analysis
language:en
Short-container-title:Risk Analysis

Author:

Kalkowska Dominika A.¹,Thompson Kimberly M.¹

Affiliation:

1. Kid Risk Inc. Orlando FL USA

Funder

Center for Global Health

Publisher

Wiley

Subject

Physiology (medical),Safety, Risk, Reliability and Quality

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/risa.13590

Reference32 articles.

1. Implementation of coordinated global serotype 2 oral poliovirus vaccine cessation: risks of potential non-synchronous cessation

2. Implementation of coordinated global serotype 2 oral poliovirus vaccine cessation: risks of inadvertent trivalent oral poliovirus vaccine use

3. Planning for globally coordinated cessation of bivalent oral poliovirus vaccine: risks of non-synchronous cessation and unauthorized oral poliovirus vaccine use

4. Maintenance and intensification of bivalent oral poliovirus vaccine use prior to its coordinated global cessation;Duintjer Tebbens R. J.;Journal of Vaccines and Vaccination,2016

5. Poliovirus containment risks and their management

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Review of Poliovirus Transmission and Economic Modeling to Support Global Polio Eradication: 2020–2024;Pathogens;2024-05-22

2. Oral polio vaccine stockpile modeling: insights from recent experience;Expert Review of Vaccines;2023-09-29

3. Health Economic Analysis of Antiviral Drugs in the Global Polio Eradication Endgame;Medical Decision Making;2023-08-14

4. Coordinated global cessation of oral poliovirus vaccine use: Options and potential consequences;Risk Analysis;2023-06-21

5. Complexity of options related to restarting oral poliovirus vaccine (OPV) in national immunization programs after OPV cessation;Gates Open Research;2023-04-17